| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 156 |
| 1 | TEMOZOLOMIDE | 67 |
| 2 | TRASTUZUMAB | 60 |
| 3 | DEXAMETHASONE | 53 |
| 4 | DEXAMETHASONE 1.5 MG | 53 |
| 5 | NIVOLUMAB | 43 |
| 6 | ADO-TRASTUZUMAB EMTANSINE | 41 |
| 7 | CARBOPLATIN | 41 |
| 8 | IPILIMUMAB | 38 |
| 9 | LEVETIRACETAM | 37 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUOROESTRADIOL F 18 | 1 | 0.0455 |
| 1 | DORDAVIPRONE | 2 | 0.0155 |
| 2 | LOMUSTINE | 15 | 0.0058 |
| 3 | ADO-TRASTUZUMAB EMTANSINE | 41 | 0.0048 |
| 4 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 5 | REPOTRECTINIB | 1 | 0.0036 |
| 6 | PANTHENOL | 1 | 0.0034 |
| 7 | TEMOZOLOMIDE | 67 | 0.0031 |
| 8 | BRIGATINIB | 10 | 0.0027 |
| 9 | PALIFERMIN | 1 | 0.0026 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Activator [EPC] | 2 | 0.0155 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 2 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 104 | 0.0011 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 156 | 0.0008 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 60 | 0.0008 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 38 | 0.0008 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 9 | Alkylating Drug [EPC] | 104 | 0.0004 |